AU Stock MarketDetailed Quotes

Mayne Pharma Group Ltd (MYXDA)

Watchlist
  • 3.540
  • 0.0000.00%
20min DelayMarket Closed Jan 24 16:00 AET
303.65MMarket Cap-1.11P/E (Static)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Mayne Pharma Group Ltd (MYXDA) Revenue Breakdown Overview

By Business/Source

Currency:AUD
2022/FY
Stock NameRevenueRatio
Portfolio Products Division269.09M63.48%
Metrics Contract Services90.77M21.41%
International54.37M12.83%
Branded Products Division10.57M2.49%
Royalty revenue-882K-0.21%

By Country/Region

Currency:AUD
2022/FY
Stock NameRevenueRatio
United States370.92M87.32%
Australia and New Zealand33.7M7.93%
Canada9.06M2.13%
Europe6.25M1.47%
Asia4.88M1.15%
Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +3.17%
Sample Name
Sample Code
 -0.27%
Sample Name
Sample Code
 -0.43%
4
CNOOC
00883
-0.83%
5
PETROCHINA
00857
-1.67%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +62.04%
Sample Name
Sample Code
 +51.30%
Sample Name
Sample Code
 +46.36%
4
Loongson Technology Corporation
688047
+36.75%
5
Business-intelligence Of Oriental Nations Corporation
300166
+31.45%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 7 Eastern Time, as the US-Iran negotiations entered a critical window amid external expectations and various parties' strategic maneu Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -